Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).
Shimoda M, Katakura Y, Mashiko A, Iwamoto M, Nakanishi S, Anno T, Kawasaki F, Obata A, Fushimi Y, Sanada J, Kohara K, Isobe H, Iwamoto Y, Hirukawa H, Tatsumi F, Kimura Y, Kimura T, Mune T, Kaku K, Kaneto H.
Shimoda M, et al. Among authors: obata a.
Front Endocrinol (Lausanne). 2024 Oct 21;15:1412553. doi: 10.3389/fendo.2024.1412553. eCollection 2024.
Front Endocrinol (Lausanne). 2024.
PMID: 39497800
Free PMC article.
Clinical Trial.